We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Method of Analyzing ECG Test Helps Clinicians Predict Sudden Cardiac Arrest

By HospiMedica International staff writers
Posted on 14 Dec 2023

Sudden cardiac arrest is a critical and often fatal condition that occurs when an electrical circuit in the heart malfunctions and suddenly halts its beating. More...

This medical emergency results in a 90% fatality rate. Identifying high-risk patients for sudden cardiac arrest allows for proactive treatments, such as medication or the surgical implantation of a defibrillator to revive a halted heart. However, over the last two decades, it has become increasingly difficult to accurately identify ideal candidates for defibrillator implantation. Now, a novel approach discovered by researchers utilizes a common cardiovascular test to predict this heart malfunction.

Investigators in the Smidt Heart Institute at Cedars-Sinai (Los Angeles, CA, USA) examined the progression of electrocardiogram (ECG) changes in individuals who later experienced cardiac arrest against those who did not. The study participants were selected from ongoing community-based research projects in Oregon and California, focusing on individuals with at least two ECGs. The team measured variability using six established indicators of electrical risk, including heart rate, left ventricular hypertrophy (heart wall thickening), and four indicators related to the heart muscle's electrical activation and recovery.

The study was conducted in two phases. Initially, the team compared ECGs from Oregon participants who suffered sudden cardiac arrest with those who did not experience such an event. Subsequently, this comparison was replicated with a similar cohort in California. In both cases, those who had sudden cardiac arrest showed a significant increase in electrical risk as indicated by their ECGs, unlike the control groups.

Upon deeper analysis, it was found that the elevated electrical risk was consistently present in the five years preceding the sudden cardiac arrest. After matching the participants based on gender, age, and the interval between their two ECGs, the researchers found that when considering all clinical conditions, baseline ECG readings, and the dynamic change in electrical risk, the latter further enhanced the prediction of risk. This new approach requires further validation through a study designed to monitor how effectively these dynamic changes can predict sudden cardiac arrest in patients over time.

“Based on these findings, we now know that electrocardiogram abnormalities are escalated over time in people who have sudden cardiac arrest compared to people who are not destined to experience the condition,” said Sumeet Chugh, MD, senior author of the study. “We can potentially leverage this dynamic change to improve how we identify candidates who will benefit the most from an implantable defibrillator.”

Related Links:
Smidt Heart Institute at Cedars-Sinai


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
New
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.